Suppr超能文献

长期肝素治疗后对肝素抗增殖活性产生抗性的大鼠主动脉平滑肌细胞的特性分析

Characterization of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment.

作者信息

Bârzu T, Herbert J M, Desmoulière A, Carayon P, Pascal M

机构信息

Sanofi Recherche Centre Choay, Gentilly, France.

出版信息

J Cell Physiol. 1994 Aug;160(2):239-48. doi: 10.1002/jcp.1041600205.

Abstract

Vascular smooth muscle cells (SMC) do not represent a homogeneous population (Schwartz et al., 1990, Am. J. Pathol. 136: 1417-1428). Cellular clones resistant to the antiproliferative activity of heparin were isolated from rat aortic SMC cultures (Pukac et al., 1990, Cell Regul., 1:435-443; San Antonio et al., 1993, Arterioscler. Thromb., 13:748-757) and from explant of human arterial restenotic lesions (Chan et al., 1993, Lancet, 341:341-342). We have shown in the present study that long-term treatment (growth medium supplemented with 200 micrograms/ml heparin, from the second to the tenth passage) of rat aortic SMC, without cell cloning, resulted in a significant loss of sensitivity to the growth inhibition by heparin and its derivatives. The heparin resistance was stable after growing cells for two passages in heparin-free medium, suggesting the selection of a particular phenotype. We tried to characterize these cells and to determine the causes of the resistance to the growth inhibition by heparin. Heparin-treated SMC (HT-SMC) were smaller than their control culture at the same passage, expressed less alpha-SM actin, and did not overgrow after reaching confluence. As in the heparin-resistant clones (San Antonio et al., 1993, Cell Regul., 1:435-443) expression of alpha-SM actin could be increased in HT-SMC by heparin addition before Western blotting. Heparin resistance was associated with a tenfold decrease in [3H]-heparin binding capacity (Bmax = 1.9 x 10(6) sites per cell) compared to control cultures (Bmax = 1.7 x 10(7) sites per cell), which was irreversible after growing the cells for two additional passages in heparin-free medium. We also investigated protein kinase C (PKC) in HT-SMC in terms of both enzymatic activity and protein expression (evaluated by [3H]-staurosporine and [3H]-phorbol-12,13-dibutyrate binding). We found that HT-SMC had only half the PKC activity and expression as control SMC. Therefore, long-term treatment of rat aortic SMC with heparin allowed the selection of a less differentiated subpopulation of cells, exhibiting low sensitivity to the growth inhibition by heparin, which could be related to the low capacity of binding heparin and to a lower PKC activity and/or expression.

摘要

血管平滑肌细胞(SMC)并非是一个同质群体(施瓦茨等人,1990年,《美国病理学杂志》136卷:1417 - 1428页)。从大鼠主动脉平滑肌细胞培养物(普卡克等人,1990年,《细胞调控》1卷:435 - 443页;圣安东尼奥等人,1993年,《动脉硬化血栓形成》13卷:748 - 757页)以及人动脉再狭窄病变的外植体(陈等人,1993年,《柳叶刀》341卷:341 - 342页)中分离出了对肝素抗增殖活性具有抗性的细胞克隆。我们在本研究中表明,对大鼠主动脉平滑肌细胞进行长期处理(从第二代到第十代,在生长培养基中添加200微克/毫升肝素),不进行细胞克隆,会导致对肝素及其衍生物生长抑制的敏感性显著丧失。在无肝素培养基中培养两代细胞后,肝素抗性保持稳定,这表明选择了一种特定的表型。我们试图对这些细胞进行表征,并确定其对肝素生长抑制产生抗性的原因。肝素处理的平滑肌细胞(HT - SMC)在同一代时比其对照培养物小,α - SM肌动蛋白表达较少,汇合后不会过度生长。与肝素抗性克隆情况相同(圣安东尼奥等人,1993年,《细胞调控》1卷:435 - 443页),在蛋白质印迹分析前添加肝素可使HT - SMC中α - SM肌动蛋白的表达增加。与对照培养物(Bmax = 1.7×10⁷个位点/细胞)相比,肝素抗性与[³H] - 肝素结合能力降低十倍相关(Bmax = 1.9×10⁶个位点/细胞),在无肝素培养基中再培养两代细胞后,这种情况不可逆。我们还从酶活性和蛋白质表达方面(通过[³H] - 星形孢菌素和[³H] - 佛波醇 - 12,13 - 二丁酸酯结合进行评估)研究了HT - SMC中的蛋白激酶C(PKC)。我们发现HT - SMC的PKC活性和表达仅为对照平滑肌细胞的一半。因此,用肝素对大鼠主动脉平滑肌细胞进行长期处理可选择出一个分化程度较低的细胞亚群,该亚群对肝素的生长抑制表现出低敏感性,这可能与肝素结合能力低以及PKC活性和/或表达较低有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验